Outcomes-Based Contracts

All articles by Outcomes-Based Contracts

Prime Therapeutics signs outcomes-based contract for Jardiance
Prime Therapeutics signs outcomes-based contract for Jardiance
Alison Kanski
January 30, 2018
8:14 pm

Jardiance treats patients with type 2 diabetes and heart disease, lowering blood sugar and reducing the risk of death from heart disease.

Five things for pharma marketers to know: Tuesday, July 11, 2017
Five things for pharma marketers to know: Tuesday, July 11, 2017
Virginia Lau
July 11, 2017
2:09 pm

Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics

Five things for pharma marketers to know: Wednesday, May 31, 2017
Five things for pharma marketers to know: Wednesday, May 31, 2017
Kevin McCaffrey
May 31, 2017
2:35 pm

BMS partners on Opdivo combo; one-quarter of insurers have signed an outcomes-based contract with a drugmaker; rebates do not lead to savings for Medicare beneficiaries

Five things for pharma marketers to know: Tuesday, May 30, 2017
Five things for pharma marketers to know: Tuesday, May 30, 2017
Jaimy Lee
May 30, 2017
2:20 pm

Harvard Pilgrim signs two outcomes contracts with AstraZeneca; lobbyists fight over drug-pricing proposals; docs say no to adult ADHD screening test

How Pharma Can Benefit from the Transformation of Pharmacy
How Pharma Can Benefit from the Transformation of Pharmacy
Mark Worman, McCann Health, and Sandra Carey, McCann Pharmacy Initiative
May 16, 2017
5:30 pm

The pharmacist is being recognized as a key player on the healthcare stage and a main protagonist in the delivery of effective, outcomes-based care.

Day 2 at JP Morgan: Change is coming, but which drugmakers will stay on top?
Day 2 at JP Morgan: Change is coming, but which drugmakers will stay on top?
Jaimy Lee
January 11, 2017
4:00 pm

J&J’s CEO may be right. Customers of all kinds are demanding change.

  • From Our Partners